Conversely, NPM1MT had a hi gher proportion of primary AML (p = 0.0001), normal karyotype (p < 0.0001), and FLT3-ITDPOS (p < 0.0001) patients. This evidence concerns the gene FLT3 and acute myeloid leukemia.